Persistent Brain Metastasis in GCT of Testis — When Cisplatin-Based Chemotherapy Does Not Achieve Radiological Response
Clinical scenario
This protocol addresses germ cell tumour of the testis presenting with brain metastases at initial diagnosis. Brain metastases in this setting occur in the context of initial metastatic disease and require coordinated systemic and intracranial management from the outset.
Previous treatment & failure condition
Initial treatment consisted of cisplatin-based chemotherapy — including BEP ×4 or VIP ×4 per IGCCCG poor-prognosis risk stratification, with consideration of consolidation stereotactic radiotherapy to brain metastases. This protocol applies when that prior line failed to achieve its intended goals: normalisation of serum tumour markers and radiological response of brain and systemic metastases on MRI and cross-sectional imaging.
Next-step approach (partial overview)
Following incomplete response to cisplatin-based chemotherapy, the protocol may involve a surgical intervention directed at a persistent intracranial lesion — provided specific clinical criteria are met. The suitability and scope of the intervention depend on multiple factors assessed at the time of restaging.
Full decision criteria, sequencing, and management algorithm available via the protocol link below.
Treatment goals
Complete resection of brain metastasis with no residual intracranial disease on post-treatment MRI.
References
- Brain metastases occur in the context of initial metastatic disease, systemic relapse and rarely as an isolated site of relapse.
- Chemotherapy as initial treatment proved effective in a first-line setting (potentially even as dose-intensified therapy upfront) with data also supporting the use of multimodal treatment particularly in relapsed disease.
- Surgery may be considered in cases with a persistent solitary metastasis, depending on the systemic disease status, histology of the primary tumour and the location of the metastasis.
View source ↗